ProCE Banner Activity

Medical Minute 3 — Conventional and New Therapies for Primary Hyperoxaluria Type 1


This downloadable slide set for nephrologists, urologists, and primary care providers presents an expert discussion of conventional and emerging therapy for primary hyperoxaluria (PH), including the use of RNAi treatment and how to manage patients progressing to chronic kidney disease.

Released: January 16, 2024



John C. Lieske

John C. Lieske, MD

Professor of Medicine
Mayo Clinic
Division of Nephrology and Hypertension
Rochester, Minnesota

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from Novo Nordisk.

Novo Nordisk